These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17867558)

  • 1. Preparation, characterization and uptake by primary cultured rat hepatocytes of liposomes surface-modified with glycyrrhetinic acid.
    Mao SJ; Bi YQ; Jin H; Wei DP; He R; Hou SX
    Pharmazie; 2007 Aug; 62(8):614-9. PubMed ID: 17867558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preparation of liposomes surface-modified with glycyrrhetinic acid targeting to hepatocytes].
    Mao SJ; Hou SX; Jin H; Zhang LK; Jiang-Bin
    Zhongguo Zhong Yao Za Zhi; 2003 Apr; 28(4):328-31. PubMed ID: 15139140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of galactose-modified liposomes by a nonaqueous enzymatic reaction.
    Guo BH; Cheng Y; Lin LP; Lin DH; Wu W
    J Liposome Res; 2011 Sep; 21(3):255-60. PubMed ID: 21545336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of albumin nanoparticle surface modified with glycyrrhizin by primary cultured rat hepatocytes.
    Mao SJ; Hou SX; He R; Zhang LK; Wei DP; Bi YQ; Jin H
    World J Gastroenterol; 2005 May; 11(20):3075-9. PubMed ID: 15918193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of mPEG-PLA modified liposomes loaded glycyrrhetinic acid.
    Lu Y; Li J; Wang G
    Int J Pharm; 2008 May; 356(1-2):274-81. PubMed ID: 18304766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-tumor performance of docetaxel liposomes surface-modified with glycyrrhetinic acid.
    Li J; Xu H; Ke X; Tian J
    J Drug Target; 2012 Jun; 20(5):467-73. PubMed ID: 22577855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of liposomes surface-modified with glycyrrhizin by primary cultured rat hepatocytes.
    Osaka S; Tsuji H; Kiwada H
    Biol Pharm Bull; 1994 Jul; 17(7):940-3. PubMed ID: 8000382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPLC assay and pharmacokinetics and tissue distribution study of glycyrrhetinic acid liposomes modified with galactosylated lipid.
    Guo BH; Cheng Y; Wu W; Lin LP; Lin DH
    J Liposome Res; 2012 Jun; 22(2):120-7. PubMed ID: 22313057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
    Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q
    Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High lung uptake of 99mTc-multilamellar liposomes after intravenous administration in rats and rabbits.
    Ninio S; Yamboliev I; Kovacheva S
    Pharmazie; 1994 May; 49(5):353-6. PubMed ID: 8016181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface modification of liposomes for cardiomyocytes targeting in vitro.
    Chen Y; Deng YJ; Hao YL
    Pharmazie; 2005 Mar; 60(3):238-40. PubMed ID: 15801683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification.
    Chono S; Tanino T; Seki T; Morimoto K
    J Pharm Pharmacol; 2007 Jan; 59(1):75-80. PubMed ID: 17227623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disaccharide-modified liposomes and their in vitro intracellular uptake.
    Song CK; Jung SH; Kim DD; Jeong KS; Shin BC; Seong H
    Int J Pharm; 2009 Oct; 380(1-2):161-9. PubMed ID: 19635539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A wogonin-loaded glycyrrhetinic acid-modified liposome for hepatic targeting with anti-tumor effects.
    Tian J; Wang L; Wang L; Ke X
    Drug Deliv; 2014 Nov; 21(7):553-9. PubMed ID: 24215357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of carrier-mediated uptake of epirubicin reduces cytotoxicity in primary culture of rat hepatocytes.
    Iwakiri T; Okumura M; Hidaka M; Kumagai Y; Ichihara E; Kawano Y; Arimori K
    J Appl Toxicol; 2008 Apr; 28(3):329-36. PubMed ID: 17604344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced distribution and extended elimination of glycyrrhetinic acid in mice liver by mPEG-PLA modified (mPEGylated) liposome.
    Li J; Yu H; Li S; Wang GJ
    J Pharm Biomed Anal; 2010 Apr; 51(5):1147-53. PubMed ID: 20005656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 2. In vitro and in vivo uptake results.
    Popielarski SR; Hu-Lieskovan S; French SW; Triche TJ; Davis ME
    Bioconjug Chem; 2005; 16(5):1071-80. PubMed ID: 16173782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin.
    Wang SN; Deng YH; Xu H; Wu HB; Qiu YK; Chen DW
    Eur J Pharm Biopharm; 2006 Jan; 62(1):32-8. PubMed ID: 16226883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycyrrhetinic Acid Liposomes Containing Mannose-Diester Lauric Diacid-Cholesterol Conjugate Synthesized by Lipase-Catalytic Acylation for Liver-Specific Delivery.
    Chen J; Chen Y; Cheng Y; Gao Y
    Molecules; 2017 Sep; 22(10):. PubMed ID: 28946644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation of cationic liposomes and its role in enhancing cellular uptake of antisense oligonucleotides].
    Chen HL; Liang WQ; Shao JB; Chen Z
    Yao Xue Xue Bao; 2004 Jan; 39(1):72-6. PubMed ID: 15127587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.